Teen Screen

Ativan Celexa Cymbalta

Effexor

 

 

Lexapro Paxil Prozac   Strattera
Sarafem Wellbutrin Vyvnase Xanax Haldol
Zoloft Seroquel Klonopin Adderall Risperdal

Risperdal

Ambien Valium Ritalin Zyprexa
   

Medication Withdrawal

Home Page  -Abilify  Ativan - Celexa - Cymbalta - Effexor - Klonopin - Lexapro - Paxil - Prozac - Risperdal -Ritalin - Sarafem - Seroquel - Strattera - Valium - Wellbutrin - Xanax - Zoloft Weight Gain Withdrawal                                      

  Being able to return to a full productive life is the goal of so many that currently use or have used psychotropic medication. Our goal is to provide information that will help you  overcome the drug side effects and regain your full potential of health.

 

Along the way - REMEMBER - It is the DRUG - It Is Not You

 
 

Antidepressants

 
  Currently, Lexapro is the top searched for antidepressant on the Internet. Lexapro has now taken over Zoloft for the number one spot.  
  Lexapro being number one is not due to better effectiveness, fewer side effects or for any other reason, other than marketing. You were probably given a free sample of Lexapro by your doctor and that is how you first started taking Lexapro.  
  You are probably doing research on Lexapro at the moment due to side effects and that is how and why you found this Web Site. Lexapro seems to have the common side effects of fatigue, weight gain and side effects in the intestinal area.  
  You can get off of Lexapro and you can get rid of Lexapro side effects. Click here to read how.  
Celexa is increasing the number of clicks each day on the Internet and should overtake Lexapro in 2007.

There is a solution to taper of Klonopin and other benzodiazepines. Click here

By PAUL ELIAS, AP Biotechnology Writer Tue Sep 12, 5:27 PM ET

SAN FRANCISCO - Stanford University will bar physicians working at its two hospitals from accepting even the tiniest gifts from drug industry sales representatives to try to eliminate corporate influence from medical decisions, the school announced Tuesday.
 

The policy takes effect Oct. 1 and also bans accepting gifts from other companies such as medical device makers that do business with the hospitals. The policy also prohibits the doctors from accepting free drug samples and publishing articles in science journals that were ghost written by corporate authors. The industry's sales force also would be prohibited from areas where patients are seen and from dropping in without appointments, a common sales tactic.

Even coffee mugs, pens and other trinkets doled out by drug companies can't be accepted anymore.

Yale University and the University of Pennsylvania have announced similar policies and several other institutions are considering gift bans as they grapple with conflict of interest concerns and rising health care costs.
 

In January, an article in the Journal of the American Medical Association said current relations with pharmaceutical representatives created conflicts of interest and urged academic medical centers to take the lead in adopting reforms. The article said the drug industry spends about $19 billion annually marketing to doctors.

"Gift giving creates a reciprocal obligation that is a powerful force, and pharmaceutical companies know this very well," said David Magnus, director of the Stanford Center for Biomedical Ethics who helped write the new policy. "So we're discouraging it from happening anywhere at the medical center."